Price $20.38 |
Market Cap
142.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
17.9
|
P/B
8.86
|
P/S
3.43
|
Dividend %
2.20%
|
|
P/CF
30.3
|
P/FCF
18.2
|
Op. Cash Flow
13.5K
|
FCF
1.4
|
|
Op. Margin
29.10%
|
Net Margin
19.30%
|
ROE
56.70%
|
ROI
36.00%
|
|
ROA
32.70%
|
EPS Growth
572.80%
|
Current Ratio
2.4
|
Debt/Equity
14.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Xtant Medical Holdings Inc (XTNT) | $0.64 | - | - | 13.5M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.71 | - | - | 4.8M | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.22 | - | - | 31.1M | Strong Buy |
| iCAD Inc (ICAD) | $3.67 | - | - | 64.7M | Strong Buy |
| Enzon Pharmaceuticals Inc (ENZN) | $0.38 | - | - | 17.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
